Tabit et al. reported that although eNOS expression was similar between venous ECs isolated from T2DM patients and nondiabetic individuals, insulin-induced eNOS activation was impaired in T2DM ECs, which was ameliorated by a PKC-specific inhibitor [110]. This evidence concerns the gene PRRT2 and type 2 diabetes mellitus.